Antituberculosis therapy and imatinib for chronic myeloid leukemia.
Sorà
Federica
F
De Matteis
Silvia
S
Di Mario
Antonella
A
Maiuro
Giuseppe
G
Laurenti
Luca
L
Chiusolo
Patrizia
P
Ardito
Fausta
F
Leone
Giuseppe
G
Sica
Simona
S
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000995:Antitubercular Agents / Q000627:therapeutic use; D001549:Benzamides; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D000995:Antitubercular Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate